Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn.
Hans Peter Bøhn is chairman of PCI Biotech and shall open the extraordinary general meeting of the Company on 14 September 2018. Mr. Bøhn holds 83,556 shares, representing 0.3 per cent of the share capital of PCI Biotech. By close of business on 13 September 2018, Mr. Bøhn had received powers of attorney to represent and vote for 6,139,976 additional shares. 2,730,885 of the powers of attorney are without voting instructions. In total, Mr. Bøhn will represent and vote for 24.9 per cent of the share capital. The powers of attorney are only valid at the extraordinary general meeting on 14 September 2018.
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CFO, firstname.lastname@example.org, Mobile: +47 9400 5757
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.